Possibly already been shared:
https://www.fiercepharma.com/pharma/slow-year-for-biotech-pharma-m-a-will-drugmakers-look-for-bolt-deals-or-large-transactions
As for the size of potential deals, the RBC analysts said they expect single-asset companies in mid- to late-stage clinical development valued at around $1 billion to $5 billion will be the “sweet spot” for most M&A in 2022,
- Forums
- ASX - By Stock
- PER
- For General Information
For General Information, page-39
-
- There are more pages in this discussion • 3,488 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
7.2¢ |
Change
0.002(2.86%) |
Mkt cap ! $66.26M |
Open | High | Low | Value | Volume |
7.4¢ | 7.4¢ | 7.1¢ | $32.62K | 451.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 88164 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.3¢ | 58322 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 83320 | 0.072 |
7 | 47148 | 0.070 |
2 | 28980 | 0.069 |
3 | 33055 | 0.068 |
2 | 109310 | 0.067 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 63371 | 2 |
0.078 | 75476 | 2 |
0.079 | 175123 | 2 |
0.080 | 287231 | 3 |
0.081 | 25000 | 1 |
Last trade - 12.08pm 31/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online